gabapentin
Generic: gabapentin
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8468
Product ID
68788-8468_bbb8f028-c7fc-4d19-af5b-236d122ebb30
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214957
Listing Expiration
2026-12-31
Marketing Start
2023-06-26
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888468
Hyphenated Format
68788-8468
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA214957 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (68788-8468-1)
- 30 TABLET in 1 BOTTLE (68788-8468-3)
- 60 TABLET in 1 BOTTLE (68788-8468-6)
- 120 TABLET in 1 BOTTLE (68788-8468-8)
- 90 TABLET in 1 BOTTLE (68788-8468-9)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bbb8f028-c7fc-4d19-af5b-236d122ebb30", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310434"], "spl_set_id": ["180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8468-1)", "package_ndc": "68788-8468-1", "marketing_start_date": "20230626"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8468-3)", "package_ndc": "68788-8468-3", "marketing_start_date": "20230626"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8468-6)", "package_ndc": "68788-8468-6", "marketing_start_date": "20230626"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (68788-8468-8)", "package_ndc": "68788-8468-8", "marketing_start_date": "20230626"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8468-9)", "package_ndc": "68788-8468-9", "marketing_start_date": "20230626"}], "brand_name": "GABAPENTIN", "product_id": "68788-8468_bbb8f028-c7fc-4d19-af5b-236d122ebb30", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-8468", "generic_name": "Gabapentin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20230626", "listing_expiration_date": "20261231"}